News
President Donald Trump's sweeping new tariffs on dozens of countries took effect on Thursday, fulfilling a long-promised ...
Vinay Prasad, who was recently ousted as the top vaccine and gene therapy regulator at the US Food and Drug Administration ...
Dr. Vinay Prasad, a controversial critic of the US Food and Drug Administration who took a top role at the regulatory agency ...
Vinay Prasad, a top vaccine regulator ousted from the Food and Drug Administration (FDA) late last month, is set to return to ...
Vinay Prasad, previously critical of U.S. COVID-19 policies, has returned to his role managing vaccine and gene therapy regulation at the FDA, days after his departure. His leadership saw controversy ...
Vinay Prasad has returned to the U.S. Food and Drug Administration as the director of the Center for Biologics Evaluation and Research after a brief departure. Previously appointed in May, Prasad is ...
Vinay Prasad, MD, MPH, who was appointed to run the FDA's Center for Biologics Evaluation and Research (CBER) in May, then ...
Vinay Prasad, the FDA’s top vaccine and gene therapy regulator, was the target of a right-wing pressure campaign over his ...
Vinay Prasad, M.D., has rejoined the FDA, the latest turn in a monthslong stretch of leadership turnover at the agency. | “At ...
Vinay Prasad is returning to the U.S. Food and Drug Administration to oversee vaccine, gene therapy, and blood product regulation. Previously the director of the Center for Biologics Evaluation and ...
Vinay Prasad is returning to his role at the U.S. Food and Drug Administration, a little more than a week after he had left ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results